Firm focuses on venom-based paediatric MS treatment
Firm focuses on venom-based paediatric MS treatment
Nutra Pharma, a US-based biotechnology company specialising in the acquisition, licensing, and commercialisation of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, has announced it has filed an application with the US Food and Drug Administration (FDA) for orphan drug status for its investigational drug RPI-78M as a treatment for paediatric multiple sclerosis (MS)..... Read More - http://www.ms-uk.org/emergingtherapies
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 1376 Views
-
Last post by NHE
-
- 0 Replies
- 801 Views
-
Last post by NHE
-
- 5 Replies
- 2212 Views
-
Last post by Jaded
-
- 0 Replies
- 8716 Views
-
Last post by NHE
-
- 0 Replies
- 3877 Views
-
Last post by NHE
-
- 0 Replies
- 2086 Views
-
Last post by Cece
-
- 0 Replies
- 1829 Views
-
Last post by frodo
-
- 0 Replies
- 2297 Views
-
Last post by NHE
-
- 2 Replies
- 994 Views
-
Last post by NHE